Comparison · NCT03089983-4b5f550e
Standard Isoniazid (INH) for 26 Weeks vs Short-course Isoniazid + Rifapentine (INH + RIF) for 12 Weeks: TB Treatment Completion Rates in Prison
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Standard Isoniazid (INH) for 26 Weeks vs Short-course Isoniazid + Rifapentine (INH + RIF) for 12 Weeks: TB Treatment Completion Rates in Prison. Trial comparisons, record NCT03089983-4b5f550e. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03089983-4b5f550e
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.75 | 0.676 | 0.812 | wilson | |
| Risk in group 2 | 0.83 | 0.763 | 0.881 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0801 | -0.17 | 0.0116 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.904 | 0.804 | 1.02 | log | |
| Odds ratio, group 1 over group 2 | 0.614 | 0.351 | 1.07 | log | |
| Number needed to treat, for one fewer participant with the outcome on Standard Isoniazid (INH) for 26 Weeks than on Short-course Isoniazid + Rifapentine (INH + RIF) for 12 Weeks | 12.5 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Standard Isoniazid (INH) for 26 Weeks | Participants will be randomized to receive INH, the standard of care in Malaysia, for 26 weeks while in prison as TB preventative treatment | 114 | 152 | OG000 |
| Group 2 | Short-course Isoniazid + Rifapentine (INH + RIF) for 12 Weeks | Participants will be randomized to receive INH + RIF as TB preventative treatment for 12 weeks while in prison. | 127 | 153 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- TB Treatment Completion Rates in Prison
- Description
TB treatment completion in prison will be verified using medical records. All TB treatment in prison will be administered under directly observed therapy (DOTs), and treatment administration will be recorded in the participant's prison medical record. Data presented here is the number of participants that completed TB treatment of those that initiated treatment.
- Time frame
- 3 to 6 months
- Population
Source ClinicalTrials.gov
Trial
- Title
- Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings
- NCT number
- NCT03089983
- Phases
- NA
- Conditions
- Opioid Dependence, Addiction, HIV/AIDS, Tuberculosis, Hepatitis
- Interventions
- Isoniazid, Rifapentine
- Lead sponsor
- Yale University
- Results first posted
- 2026-02-09
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03089983?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03089983-4b5f550e